These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21242994)

  • 1. LBH589, a deacetylase inhibitor, induces apoptosis in adult T-cell leukemia/lymphoma cells via activation of a novel RAIDD-caspase-2 pathway.
    Hasegawa H; Yamada Y; Tsukasaki K; Mori N; Tsuruda K; Sasaki D; Usui T; Osaka A; Atogami S; Ishikawa C; Machijima Y; Sawada S; Hayashi T; Miyazaki Y; Kamihira S
    Leukemia; 2011 Apr; 25(4):575-87. PubMed ID: 21242994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia.
    Vilas-Zornoza A; Agirre X; Abizanda G; Moreno C; Segura V; De Martino Rodriguez A; José-Eneriz ES; Miranda E; Martín-Subero JI; Garate L; Blanco-Prieto MJ; García de Jalón JA; Rio P; Rifón J; Cigudosa JC; Martinez-Climent JA; Román-Gómez J; Calasanz MJ; Ribera JM; Prósper F
    Leukemia; 2012 Jul; 26(7):1517-26. PubMed ID: 22307227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIDDosome-independent tumor suppression by Caspase-2.
    Manzl C; Peintner L; Krumschnabel G; Bock F; Labi V; Drach M; Newbold A; Johnstone R; Villunger A
    Cell Death Differ; 2012 Oct; 19(10):1722-32. PubMed ID: 22595758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines.
    LaBonte MJ; Wilson PM; Fazzone W; Groshen S; Lenz HJ; Ladner RD
    BMC Med Genomics; 2009 Nov; 2():67. PubMed ID: 19948057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy.
    Ellis L; Bots M; Lindemann RK; Bolden JE; Newbold A; Cluse LA; Scott CL; Strasser A; Atadja P; Lowe SW; Johnstone RW
    Blood; 2009 Jul; 114(2):380-93. PubMed ID: 19383971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PIDD mediates and stabilizes the interaction between RAIDD and caspase-2 for the PIDDosome assembly.
    Jang TH; Park HH
    BMB Rep; 2013 Sep; 46(9):471-6. PubMed ID: 24064063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HDAC inhibitor, panobinostat, induces apoptosis by suppressing the expresssion of specificity protein 1 in oral squamous cell carcinoma.
    Jeon YJ; Ko SM; Cho JH; Chae JI; Shim JH
    Int J Mol Med; 2013 Oct; 32(4):860-6. PubMed ID: 23877235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA).
    Mehdi O; Françoise S; Sofia CL; Urs G; Kevin Z; Bernard S; Igor S; Anabela CD; Dominique L; Eric M; Ali O
    Pancreatology; 2012; 12(2):146-55. PubMed ID: 22487525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TSA-induced cell death in prostate cancer cell lines is caspase-2 dependent and involves the PIDDosome.
    Taghiyev AF; Guseva NV; Glover RA; Rokhlin OW; Cohen MB
    Cancer Biol Ther; 2006 Sep; 5(9):1199-205. PubMed ID: 17110788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic therapy.
    Sasaki D; Imaizumi Y; Hasegawa H; Osaka A; Tsukasaki K; Choi YL; Mano H; Marquez VE; Hayashi T; Yanagihara K; Moriwaki Y; Miyazaki Y; Kamihira S; Yamada Y
    Haematologica; 2011 May; 96(5):712-9. PubMed ID: 21228036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Mechanism of the Cell Death Induced by the Histone Deacetylase Pan Inhibitor LBH589 (Panobinostat) in Wilms Tumor Cells.
    Yan-Fang T; Zhi-Heng L; Li-Xiao X; Fang F; Jun L; Gang L; Lan C; Na-Na W; Xiao-Juan D; Li-Chao S; Wen-Li Z; Pei-Fang X; He Z; Guang-Hao S; Yan-Hong L; Yi-Ping L; Yun-Yun X; Hui-Ting Z; Yi W; Mei-Fang J; Lin L; Jian N; Shao-Yan H; Xue-Ming Z; Xing F; Jian W; Jian P
    PLoS One; 2015; 10(7):e0126566. PubMed ID: 26176219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prostate cancer blocking potential of the histone deacetylase inhibitor LBH589 is not enhanced by the multi receptor tyrosine kinase inhibitor TKI258.
    Vallo S; Mani J; Stastny M; Makarević J; Juengel E; Tsaur I; Bartsch G; Haferkamp A; Blaheta RA
    Invest New Drugs; 2013 Apr; 31(2):265-72. PubMed ID: 22801803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importin β1 regulates cell growth and survival during adult T cell leukemia/lymphoma therapy.
    Ishikawa C; Senba M; Mori N
    Invest New Drugs; 2021 Apr; 39(2):317-329. PubMed ID: 32959166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antitumor interactions between MK-1775 and panobinostat in preclinical models of pancreatic cancer.
    Wang G; Niu X; Zhang W; Caldwell JT; Edwards H; Chen W; Taub JW; Zhao L; Ge Y
    Cancer Lett; 2015 Jan; 356(2 Pt B):656-68. PubMed ID: 25458954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIDDosome expression and the role of caspase-2 activation for chemotherapy-induced apoptosis in RCCs.
    Heikaus S; Pejin I; Gabbert HE; Ramp U; Mahotka C
    Cell Oncol; 2010; 32(1-2):29-42. PubMed ID: 20208132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2.
    Gupta M; Ansell SM; Novak AJ; Kumar S; Kaufmann SH; Witzig TE
    Blood; 2009 Oct; 114(14):2926-35. PubMed ID: 19641186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor-modulatory effects of Caspase-2 and Pidd1 do not require the scaffold protein Raidd.
    Peintner L; Dorstyn L; Kumar S; Aneichyk T; Villunger A; Manzl C
    Cell Death Differ; 2015 Nov; 22(11):1803-11. PubMed ID: 25857265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of parathyroid hormone-related protein promoter P2 by NF-kappaB in adult T-cell leukemia/lymphoma.
    Nadella MV; Dirksen WP; Nadella KS; Shu S; Cheng AS; Morgenstern JA; Richard V; Fernandez SA; Huang TH; Guttridge D; Rosol TJ
    Leukemia; 2007 Aug; 21(8):1752-62. PubMed ID: 17554373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat).
    Kubo M; Kanaya N; Petrossian K; Ye J; Warden C; Liu Z; Nishimura R; Osako T; Okido M; Shimada K; Takahashi M; Chu P; Yuan YC; Chen S
    Breast Cancer Res Treat; 2013 Jan; 137(1):93-107. PubMed ID: 23160924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The histone deacetylase inhibitor LBH589 (panobinostat) modulates the crosstalk of lymphocytes with Hodgkin lymphoma cell lines.
    Klein JM; Henke A; Sauer M; Bessler M; Reiners KS; Engert A; Hansen HP; von Strandmann EP
    PLoS One; 2013; 8(11):e79502. PubMed ID: 24278143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.